Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cathie Spino, ScD
University of Michigan
Principal Investigator - Imre Noth, MD
University of Virginia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arizona
Tucson, Arizona, United States
- University of Southern California
Los Angeles, California, United States
- Stanford University
Stanford, California, United States
- University of Colorado
Aurora, Colorado, United States
- Piedmont Healthcare
Austell, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- Loyola University
Maywood, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Tulane University
New Orleans, Louisiana, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Weill Cornell Medicine
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- Ohio State University
Columbus, Ohio, United States
- Temple University
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Lisa Lancaster
Nashville, Tennessee, United States
- University of Texas Southwestern
Dallas, Texas, United States
- University of Texas Health San Antonio
San Antonio, Texas, United States
- University of Utah Health
Salt Lake City, Utah, United States
- University of Virginia
Charlottesville, Virginia, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2020
- Primary completion
- 2 Mar 2026
- Completion
- 2 Mar 2026
- Last update posted
- 20 Mar 2026
- Registered enrollment
- 202
- Registry id
- NCT04300920
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.